Asymptomatic COVID-19 testing program provides clinically relevant data

An asymptomatic SARS-CoV-2 patient admission testing program can provide clinically relevant data, even during periods of lower transmission in which testing can be limited to patients who are not fully vaccinated, a recent study showed.
“The inception of this study was during late spring, early summer 2021. Our hospital, like other hospitals, had adopted an operational screening program for COVID-19 in which all patients (both symptomatic and asymptomatic) were tested for SARS-CoV-2 upon hospital admission,” Jennifer L. Cihlar, DO, an infectious disease specialist in the division

An asymptomatic SARS-CoV-2 patient admission testing program can provide clinically relevant data, even during periods of lower transmission in which testing can be limited to patients who are not fully vaccinated, a recent study showed.
“The inception of this study was during late spring, early summer 2021. Our hospital, like other hospitals, had adopted an operational screening program for COVID-19 in which all patients (both symptomatic and asymptomatic) were tested for SARS-CoV-2 upon hospital admission,” Jennifer L. Cihlar, DO, an infectious disease specialist in the division